Denise Pollard-Knight, Director at OncoMed Pharmaceuticals Inc (OMED), sold 64,561 shares at $24.20 ($1.6M) on 2014-06-23, disclosed to the SEC on 2014-06-25.
Open-market sale of $1.6M OMED by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.20 | 52,797 | $1.3M | 82.2% |
| 2 | $23.57 | 11,764 | $277K | 17.8% |
| Total | $24.09 avg | 64,561 | $1.6M | 100% |
| Filing → |
| OMED | SELL | 2014-12-23 | $448K | — | Filing → |
| OMED | SELL | 2014-12-10 | $717K | — | Filing → |
| OMED | SELL | 2014-12-05 | $540K | — | Filing → |